Article Details
Retrieved on: 2025-10-04 04:26:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
At ECTRIMS 2025, a staff neurologist at Cleveland Clinic discussed findings from an observational study on long-term safety risks of ocrelizumab ...
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here